Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial
Journal of Clinical Oncology - United States
doi 10.1200/jco.2004.05.128
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2004
Authors
Publisher
American Society of Clinical Oncology (ASCO)